Rittling SR - Search Results

1

Novel murine mammary epithelial cell lines that form osteolytic bone metastases: effect of strain background on tumor homing.

Chen Y, Rittling SR. Chen Y, et al. Among authors: rittling sr. Clin Exp Metastasis. 2003;20(2):111-20. doi: 10.1023/a:1022675031185. Clin Exp Metastasis. 2003. PMID: 12705632

2

Osteopontin is required for full expression of the transformed phenotype by the ras oncogene.

Wu Y, Denhardt DT, Rittling SR. Wu Y, et al. Among authors: rittling sr. Br J Cancer. 2000 Jul;83(2):156-63. doi: 10.1054/bjoc.2000.1200. Br J Cancer. 2000. PMID: 10901364 Free PMC article.

3

Detection of mouse osteopontin by western blotting.

Rittling SR, Feng F. Rittling SR, et al. Biochem Biophys Res Commun. 1998 Sep 18;250(2):287-92. doi: 10.1006/bbrc.1998.9306. Biochem Biophys Res Commun. 1998. PMID: 9753622

4

Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro.

Rittling SR, Matsumoto HN, McKee MD, Nanci A, An XR, Novick KE, Kowalski AJ, Noda M, Denhardt DT. Rittling SR, et al. J Bone Miner Res. 1998 Jul;13(7):1101-11. doi: 10.1359/jbmr.1998.13.7.1101. J Bone Miner Res. 1998. PMID: 9661074

5

Osteopontin expression in mammary gland development and tumorigenesis.

Rittling SR, Novick KE. Rittling SR, et al. Cell Growth Differ. 1997 Oct;8(10):1061-9. Cell Growth Differ. 1997. PMID: 9342184

6

Clonal nature of spontaneously immortalized 3T3 cells.

Rittling SR. Rittling SR. Exp Cell Res. 1996 Nov 25;229(1):7-13. doi: 10.1006/excr.1996.0337. Exp Cell Res. 1996. PMID: 8940243

7

Mammary tumor development in MMTV-c-myc/MMTV-v-Ha-ras transgenic mice is unaffected by osteopontin deficiency.

Feng F, Rittling SR. Feng F, et al. Among authors: rittling sr. Breast Cancer Res Treat. 2000 Sep;63(1):71-9. doi: 10.1023/a:1006466516192. Breast Cancer Res Treat. 2000. PMID: 11079161

8

Role of osteopontin in cellular signaling and toxicant injury.

Denhardt DT, Giachelli CM, Rittling SR. Denhardt DT, et al. Among authors: rittling sr. Annu Rev Pharmacol Toxicol. 2001;41:723-49. doi: 10.1146/annurev.pharmtox.41.1.723. Annu Rev Pharmacol Toxicol. 2001. PMID: 11264474 Review.

9

Role of osteopontin in tumour progression.

Rittling SR, Chambers AF. Rittling SR, et al. Br J Cancer. 2004 May 17;90(10):1877-81. doi: 10.1038/sj.bjc.6601839. Br J Cancer. 2004. PMID: 15138464 Free PMC article. Review.

10

Osteopontin deficiency reduces experimental tumor cell metastasis to bone and soft tissues.

Nemoto H, Rittling SR, Yoshitake H, Furuya K, Amagasa T, Tsuji K, Nifuji A, Denhardt DT, Noda M. Nemoto H, et al. Among authors: rittling sr. J Bone Miner Res. 2001 Apr;16(4):652-9. doi: 10.1359/jbmr.2001.16.4.652. J Bone Miner Res. 2001. PMID: 11315992

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results